CompletedNCT04660422

Advance Care Planning: Communicating With Outpatients for Vital Informed Decision

Studying Infantile neuroaxonal dystrophy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Dana-Farber Cancer Institute
Principal Investigator
James A. Tulsky, MD
Dana-Farber Cancer Institute
Intervention
VitalTalk communication skills training(other)
Enrollment
42019 enrolled
Eligibility
65 years · All sexes
Timeline
20202021

Study locations (1)

Collaborators

National Institute on Aging (NIA)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04660422 on ClinicalTrials.gov

Other trials for Infantile neuroaxonal dystrophy

Additional recruiting or active studies for the same condition.

See all trials for Infantile neuroaxonal dystrophy

← Back to all trials